Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

By F. Mégraud, S. Coenen, A. Versporten, M. Kist, M. López-Brea, A. Hirschl, L. Andersen, H. Goossens, Y. Glupczynski. Gut, 2012

888 citations recorded by the source corpus.

Subfields: Infectious Diseases, Surgery

View Paper: https://www.semanticscholar.org/paper/56b2a51d1ebb2b0e4bf3e67d8cdd7903c28e6d2f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. D. Graham
2. E. Kuipers

Citations in the corpus

• Review article: the global emergence of Helicobacter pylori antibiotic resistance (2015, neutral): “1% respectively.(22) The Japanese National”
• Helicobacter pylori infection (2013, positive): “A major reason for the failure of standard triple therapy is to be found in primary clarithromycin resistance, which is present in Europe at highly variable prevalence (6–37 %) (38); its prevalence is Germany is 10.”
• Kyoto global consensus report on Helicobacter pylori gastritis (2015, background): “The prevalence of H. pylori resistance to commonly used antimicrobial agents greatly varies geographically and is linked to consumption of antibiotics in the region, 125 so the preferred eradication regimen often differs between regions.”